Global Sustained-release Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Sustained-release Medicine market size was valued at USD 35850 million in 2023 and is forecast to a readjusted size of USD 56060 million by 2030 with a CAGR of 6.6% during review period.
Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.
Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (D
The main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.
The Global Info Research report includes an overview of the development of the Sustained-release Medicine industry chain, the market status of Hospital (Original Ground Medicine, Generic Medicine), Drugstore (Original Ground Medicine, Generic Medicine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Sustained-release Medicine.
Regionally, the report analyzes the Sustained-release Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Sustained-release Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Sustained-release Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Sustained-release Medicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Original Ground Medicine, Generic Medicine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Sustained-release Medicine market.
Regional Analysis: The report involves examining the Sustained-release Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Sustained-release Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Sustained-release Medicine:
Company Analysis: Report covers individual Sustained-release Medicine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Sustained-release Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Distribution Channel (Hospital, Drugstore).
Technology Analysis: Report covers specific technologies relevant to Sustained-release Medicine. It assesses the current state, advancements, and potential future developments in Sustained-release Medicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Sustained-release Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Sustained-release Medicine market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of value.
Market segment by Type
Chapter 1, to describe Sustained-release Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Sustained-release Medicine, with revenue, gross margin and global market share of Sustained-release Medicine from 2019 to 2024.
Chapter 3, the Sustained-release Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Sustained-release Medicine market forecast, by regions, type and distribution channel, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sustained-release Medicine.
Chapter 13, to describe Sustained-release Medicine research findings and conclusion.
Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.
Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (D
The main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.
The Global Info Research report includes an overview of the development of the Sustained-release Medicine industry chain, the market status of Hospital (Original Ground Medicine, Generic Medicine), Drugstore (Original Ground Medicine, Generic Medicine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Sustained-release Medicine.
Regionally, the report analyzes the Sustained-release Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Sustained-release Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Sustained-release Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Sustained-release Medicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Original Ground Medicine, Generic Medicine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Sustained-release Medicine market.
Regional Analysis: The report involves examining the Sustained-release Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Sustained-release Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Sustained-release Medicine:
Company Analysis: Report covers individual Sustained-release Medicine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Sustained-release Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Distribution Channel (Hospital, Drugstore).
Technology Analysis: Report covers specific technologies relevant to Sustained-release Medicine. It assesses the current state, advancements, and potential future developments in Sustained-release Medicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Sustained-release Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Sustained-release Medicine market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of value.
Market segment by Type
- Original Ground Medicine
- Generic Medicine
- Hospital
- Drugstore
- Other
- Sanofi
- Novartis
- Bayer
- Johnson & Johnson
- Takeda
- AstraZeneca
- AbbVie
- Pfizer
- Collegium Pharmaceutical, Inc
- Endo Pharmaceuticals
- Shanghai Shyndec Pharmaceutical
- Zhuhai Rundu Pharmaceutical
- China Res Double-Crane
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Sustained-release Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Sustained-release Medicine, with revenue, gross margin and global market share of Sustained-release Medicine from 2019 to 2024.
Chapter 3, the Sustained-release Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Sustained-release Medicine market forecast, by regions, type and distribution channel, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sustained-release Medicine.
Chapter 13, to describe Sustained-release Medicine research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Sustained-release Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Sustained-release Medicine by Type
1.3.1 Overview: Global Sustained-release Medicine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Sustained-release Medicine Consumption Value Market Share by Type in 2023
1.3.3 Original Ground Medicine
1.3.4 Generic Medicine
1.4 Global Sustained-release Medicine Market by Distribution Channel
1.4.1 Overview: Global Sustained-release Medicine Market Size by Distribution Channel: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Drugstore
1.4.4 Other
1.5 Global Sustained-release Medicine Market Size & Forecast
1.6 Global Sustained-release Medicine Market Size and Forecast by Region
1.6.1 Global Sustained-release Medicine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Sustained-release Medicine Market Size by Region, (2019-2030)
1.6.3 North America Sustained-release Medicine Market Size and Prospect (2019-2030)
1.6.4 Europe Sustained-release Medicine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Sustained-release Medicine Market Size and Prospect (2019-2030)
1.6.6 South America Sustained-release Medicine Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Sustained-release Medicine Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Sustained-release Medicine Product and Solutions
2.1.4 Sanofi Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Sustained-release Medicine Product and Solutions
2.2.4 Novartis Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Sustained-release Medicine Product and Solutions
2.3.4 Bayer Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Sustained-release Medicine Product and Solutions
2.4.4 Johnson & Johnson Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Sustained-release Medicine Product and Solutions
2.5.4 Takeda Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Takeda Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Sustained-release Medicine Product and Solutions
2.6.4 AstraZeneca Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Sustained-release Medicine Product and Solutions
2.7.4 AbbVie Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 AbbVie Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Sustained-release Medicine Product and Solutions
2.8.4 Pfizer Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Collegium Pharmaceutical, Inc
2.9.1 Collegium Pharmaceutical, Inc Details
2.9.2 Collegium Pharmaceutical, Inc Major Business
2.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Product and Solutions
2.9.4 Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Collegium Pharmaceutical, Inc Recent Developments and Future Plans
2.10 Endo Pharmaceuticals
2.10.1 Endo Pharmaceuticals Details
2.10.2 Endo Pharmaceuticals Major Business
2.10.3 Endo Pharmaceuticals Sustained-release Medicine Product and Solutions
2.10.4 Endo Pharmaceuticals Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.11 Shanghai Shyndec Pharmaceutical
2.11.1 Shanghai Shyndec Pharmaceutical Details
2.11.2 Shanghai Shyndec Pharmaceutical Major Business
2.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product and Solutions
2.11.4 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Shanghai Shyndec Pharmaceutical Recent Developments and Future Plans
2.12 Zhuhai Rundu Pharmaceutical
2.12.1 Zhuhai Rundu Pharmaceutical Details
2.12.2 Zhuhai Rundu Pharmaceutical Major Business
2.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product and Solutions
2.12.4 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Zhuhai Rundu Pharmaceutical Recent Developments and Future Plans
2.13 China Res Double-Crane
2.13.1 China Res Double-Crane Details
2.13.2 China Res Double-Crane Major Business
2.13.3 China Res Double-Crane Sustained-release Medicine Product and Solutions
2.13.4 China Res Double-Crane Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 China Res Double-Crane Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Sustained-release Medicine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Sustained-release Medicine by Company Revenue
3.2.2 Top 3 Sustained-release Medicine Players Market Share in 2023
3.2.3 Top 6 Sustained-release Medicine Players Market Share in 2023
3.3 Sustained-release Medicine Market: Overall Company Footprint Analysis
3.3.1 Sustained-release Medicine Market: Region Footprint
3.3.2 Sustained-release Medicine Market: Company Product Type Footprint
3.3.3 Sustained-release Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Sustained-release Medicine Consumption Value and Market Share by Type (2019-2024)
4.2 Global Sustained-release Medicine Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY DISTRIBUTION CHANNEL
5.1 Global Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2024)
5.2 Global Sustained-release Medicine Market Forecast by Distribution Channel (2025-2030)
6 NORTH AMERICA
6.1 North America Sustained-release Medicine Consumption Value by Type (2019-2030)
6.2 North America Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
6.3 North America Sustained-release Medicine Market Size by Country
6.3.1 North America Sustained-release Medicine Consumption Value by Country (2019-2030)
6.3.2 United States Sustained-release Medicine Market Size and Forecast (2019-2030)
6.3.3 Canada Sustained-release Medicine Market Size and Forecast (2019-2030)
6.3.4 Mexico Sustained-release Medicine Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Sustained-release Medicine Consumption Value by Type (2019-2030)
7.2 Europe Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
7.3 Europe Sustained-release Medicine Market Size by Country
7.3.1 Europe Sustained-release Medicine Consumption Value by Country (2019-2030)
7.3.2 Germany Sustained-release Medicine Market Size and Forecast (2019-2030)
7.3.3 France Sustained-release Medicine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Sustained-release Medicine Market Size and Forecast (2019-2030)
7.3.5 Russia Sustained-release Medicine Market Size and Forecast (2019-2030)
7.3.6 Italy Sustained-release Medicine Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Sustained-release Medicine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
8.3 Asia-Pacific Sustained-release Medicine Market Size by Region
8.3.1 Asia-Pacific Sustained-release Medicine Consumption Value by Region (2019-2030)
8.3.2 China Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.3 Japan Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.4 South Korea Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.5 India Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.7 Australia Sustained-release Medicine Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Sustained-release Medicine Consumption Value by Type (2019-2030)
9.2 South America Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
9.3 South America Sustained-release Medicine Market Size by Country
9.3.1 South America Sustained-release Medicine Consumption Value by Country (2019-2030)
9.3.2 Brazil Sustained-release Medicine Market Size and Forecast (2019-2030)
9.3.3 Argentina Sustained-release Medicine Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Sustained-release Medicine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
10.3 Middle East & Africa Sustained-release Medicine Market Size by Country
10.3.1 Middle East & Africa Sustained-release Medicine Consumption Value by Country (2019-2030)
10.3.2 Turkey Sustained-release Medicine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Sustained-release Medicine Market Size and Forecast (2019-2030)
10.3.4 UAE Sustained-release Medicine Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Sustained-release Medicine Market Drivers
11.2 Sustained-release Medicine Market Restraints
11.3 Sustained-release Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Sustained-release Medicine Industry Chain
12.2 Sustained-release Medicine Upstream Analysis
12.3 Sustained-release Medicine Midstream Analysis
12.4 Sustained-release Medicine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Sustained-release Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Sustained-release Medicine by Type
1.3.1 Overview: Global Sustained-release Medicine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Sustained-release Medicine Consumption Value Market Share by Type in 2023
1.3.3 Original Ground Medicine
1.3.4 Generic Medicine
1.4 Global Sustained-release Medicine Market by Distribution Channel
1.4.1 Overview: Global Sustained-release Medicine Market Size by Distribution Channel: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Drugstore
1.4.4 Other
1.5 Global Sustained-release Medicine Market Size & Forecast
1.6 Global Sustained-release Medicine Market Size and Forecast by Region
1.6.1 Global Sustained-release Medicine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Sustained-release Medicine Market Size by Region, (2019-2030)
1.6.3 North America Sustained-release Medicine Market Size and Prospect (2019-2030)
1.6.4 Europe Sustained-release Medicine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Sustained-release Medicine Market Size and Prospect (2019-2030)
1.6.6 South America Sustained-release Medicine Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Sustained-release Medicine Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Sustained-release Medicine Product and Solutions
2.1.4 Sanofi Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Sustained-release Medicine Product and Solutions
2.2.4 Novartis Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Sustained-release Medicine Product and Solutions
2.3.4 Bayer Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Sustained-release Medicine Product and Solutions
2.4.4 Johnson & Johnson Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Sustained-release Medicine Product and Solutions
2.5.4 Takeda Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Takeda Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Sustained-release Medicine Product and Solutions
2.6.4 AstraZeneca Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Sustained-release Medicine Product and Solutions
2.7.4 AbbVie Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 AbbVie Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Sustained-release Medicine Product and Solutions
2.8.4 Pfizer Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Collegium Pharmaceutical, Inc
2.9.1 Collegium Pharmaceutical, Inc Details
2.9.2 Collegium Pharmaceutical, Inc Major Business
2.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Product and Solutions
2.9.4 Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Collegium Pharmaceutical, Inc Recent Developments and Future Plans
2.10 Endo Pharmaceuticals
2.10.1 Endo Pharmaceuticals Details
2.10.2 Endo Pharmaceuticals Major Business
2.10.3 Endo Pharmaceuticals Sustained-release Medicine Product and Solutions
2.10.4 Endo Pharmaceuticals Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.11 Shanghai Shyndec Pharmaceutical
2.11.1 Shanghai Shyndec Pharmaceutical Details
2.11.2 Shanghai Shyndec Pharmaceutical Major Business
2.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product and Solutions
2.11.4 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Shanghai Shyndec Pharmaceutical Recent Developments and Future Plans
2.12 Zhuhai Rundu Pharmaceutical
2.12.1 Zhuhai Rundu Pharmaceutical Details
2.12.2 Zhuhai Rundu Pharmaceutical Major Business
2.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product and Solutions
2.12.4 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Zhuhai Rundu Pharmaceutical Recent Developments and Future Plans
2.13 China Res Double-Crane
2.13.1 China Res Double-Crane Details
2.13.2 China Res Double-Crane Major Business
2.13.3 China Res Double-Crane Sustained-release Medicine Product and Solutions
2.13.4 China Res Double-Crane Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 China Res Double-Crane Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Sustained-release Medicine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Sustained-release Medicine by Company Revenue
3.2.2 Top 3 Sustained-release Medicine Players Market Share in 2023
3.2.3 Top 6 Sustained-release Medicine Players Market Share in 2023
3.3 Sustained-release Medicine Market: Overall Company Footprint Analysis
3.3.1 Sustained-release Medicine Market: Region Footprint
3.3.2 Sustained-release Medicine Market: Company Product Type Footprint
3.3.3 Sustained-release Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Sustained-release Medicine Consumption Value and Market Share by Type (2019-2024)
4.2 Global Sustained-release Medicine Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY DISTRIBUTION CHANNEL
5.1 Global Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2024)
5.2 Global Sustained-release Medicine Market Forecast by Distribution Channel (2025-2030)
6 NORTH AMERICA
6.1 North America Sustained-release Medicine Consumption Value by Type (2019-2030)
6.2 North America Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
6.3 North America Sustained-release Medicine Market Size by Country
6.3.1 North America Sustained-release Medicine Consumption Value by Country (2019-2030)
6.3.2 United States Sustained-release Medicine Market Size and Forecast (2019-2030)
6.3.3 Canada Sustained-release Medicine Market Size and Forecast (2019-2030)
6.3.4 Mexico Sustained-release Medicine Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Sustained-release Medicine Consumption Value by Type (2019-2030)
7.2 Europe Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
7.3 Europe Sustained-release Medicine Market Size by Country
7.3.1 Europe Sustained-release Medicine Consumption Value by Country (2019-2030)
7.3.2 Germany Sustained-release Medicine Market Size and Forecast (2019-2030)
7.3.3 France Sustained-release Medicine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Sustained-release Medicine Market Size and Forecast (2019-2030)
7.3.5 Russia Sustained-release Medicine Market Size and Forecast (2019-2030)
7.3.6 Italy Sustained-release Medicine Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Sustained-release Medicine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
8.3 Asia-Pacific Sustained-release Medicine Market Size by Region
8.3.1 Asia-Pacific Sustained-release Medicine Consumption Value by Region (2019-2030)
8.3.2 China Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.3 Japan Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.4 South Korea Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.5 India Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Sustained-release Medicine Market Size and Forecast (2019-2030)
8.3.7 Australia Sustained-release Medicine Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Sustained-release Medicine Consumption Value by Type (2019-2030)
9.2 South America Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
9.3 South America Sustained-release Medicine Market Size by Country
9.3.1 South America Sustained-release Medicine Consumption Value by Country (2019-2030)
9.3.2 Brazil Sustained-release Medicine Market Size and Forecast (2019-2030)
9.3.3 Argentina Sustained-release Medicine Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Sustained-release Medicine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Sustained-release Medicine Consumption Value by Distribution Channel (2019-2030)
10.3 Middle East & Africa Sustained-release Medicine Market Size by Country
10.3.1 Middle East & Africa Sustained-release Medicine Consumption Value by Country (2019-2030)
10.3.2 Turkey Sustained-release Medicine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Sustained-release Medicine Market Size and Forecast (2019-2030)
10.3.4 UAE Sustained-release Medicine Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Sustained-release Medicine Market Drivers
11.2 Sustained-release Medicine Market Restraints
11.3 Sustained-release Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Sustained-release Medicine Industry Chain
12.2 Sustained-release Medicine Upstream Analysis
12.3 Sustained-release Medicine Midstream Analysis
12.4 Sustained-release Medicine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Sustained-release Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Sustained-release Medicine Consumption Value by Distribution Channel, (USD Million), 2019 & 2023 & 2030
Table 3. Global Sustained-release Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Sustained-release Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Sustained-release Medicine Product and Solutions
Table 8. Sanofi Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Sustained-release Medicine Product and Solutions
Table 13. Novartis Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Bayer Company Information, Head Office, and Major Competitors
Table 16. Bayer Major Business
Table 17. Bayer Sustained-release Medicine Product and Solutions
Table 18. Bayer Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bayer Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Sustained-release Medicine Product and Solutions
Table 23. Johnson & Johnson Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Takeda Company Information, Head Office, and Major Competitors
Table 26. Takeda Major Business
Table 27. Takeda Sustained-release Medicine Product and Solutions
Table 28. Takeda Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Takeda Recent Developments and Future Plans
Table 30. AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Sustained-release Medicine Product and Solutions
Table 33. AstraZeneca Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. AstraZeneca Recent Developments and Future Plans
Table 35. AbbVie Company Information, Head Office, and Major Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Sustained-release Medicine Product and Solutions
Table 38. AbbVie Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. AbbVie Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Sustained-release Medicine Product and Solutions
Table 43. Pfizer Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Collegium Pharmaceutical, Inc Company Information, Head Office, and Major Competitors
Table 46. Collegium Pharmaceutical, Inc Major Business
Table 47. Collegium Pharmaceutical, Inc Sustained-release Medicine Product and Solutions
Table 48. Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Collegium Pharmaceutical, Inc Recent Developments and Future Plans
Table 50. Endo Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. Endo Pharmaceuticals Major Business
Table 52. Endo Pharmaceuticals Sustained-release Medicine Product and Solutions
Table 53. Endo Pharmaceuticals Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Endo Pharmaceuticals Recent Developments and Future Plans
Table 55. Shanghai Shyndec Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. Shanghai Shyndec Pharmaceutical Major Business
Table 57. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product and Solutions
Table 58. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Shanghai Shyndec Pharmaceutical Recent Developments and Future Plans
Table 60. Zhuhai Rundu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 61. Zhuhai Rundu Pharmaceutical Major Business
Table 62. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product and Solutions
Table 63. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Zhuhai Rundu Pharmaceutical Recent Developments and Future Plans
Table 65. China Res Double-Crane Company Information, Head Office, and Major Competitors
Table 66. China Res Double-Crane Major Business
Table 67. China Res Double-Crane Sustained-release Medicine Product and Solutions
Table 68. China Res Double-Crane Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. China Res Double-Crane Recent Developments and Future Plans
Table 70. Global Sustained-release Medicine Revenue (USD Million) by Players (2019-2024)
Table 71. Global Sustained-release Medicine Revenue Share by Players (2019-2024)
Table 72. Breakdown of Sustained-release Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Sustained-release Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Sustained-release Medicine Players
Table 75. Sustained-release Medicine Market: Company Product Type Footprint
Table 76. Sustained-release Medicine Market: Company Product Application Footprint
Table 77. Sustained-release Medicine New Market Entrants and Barriers to Market Entry
Table 78. Sustained-release Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Sustained-release Medicine Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Sustained-release Medicine Consumption Value Share by Type (2019-2024)
Table 81. Global Sustained-release Medicine Consumption Value Forecast by Type (2025-2030)
Table 82. Global Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024)
Table 83. Global Sustained-release Medicine Consumption Value Forecast by Distribution Channel (2025-2030)
Table 84. North America Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 87. North America Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 88. North America Sustained-release Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Sustained-release Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 93. Europe Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 94. Europe Sustained-release Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Sustained-release Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 99. Asia-Pacific Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 100. Asia-Pacific Sustained-release Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Sustained-release Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 105. South America Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 106. South America Sustained-release Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Sustained-release Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 111. Middle East & Africa Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 112. Middle East & Africa Sustained-release Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Sustained-release Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Sustained-release Medicine Raw Material
Table 115. Key Suppliers of Sustained-release Medicine Raw Materials
Table 1. Global Sustained-release Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Sustained-release Medicine Consumption Value by Distribution Channel, (USD Million), 2019 & 2023 & 2030
Table 3. Global Sustained-release Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Sustained-release Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Sustained-release Medicine Product and Solutions
Table 8. Sanofi Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Sustained-release Medicine Product and Solutions
Table 13. Novartis Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Bayer Company Information, Head Office, and Major Competitors
Table 16. Bayer Major Business
Table 17. Bayer Sustained-release Medicine Product and Solutions
Table 18. Bayer Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bayer Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Sustained-release Medicine Product and Solutions
Table 23. Johnson & Johnson Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Takeda Company Information, Head Office, and Major Competitors
Table 26. Takeda Major Business
Table 27. Takeda Sustained-release Medicine Product and Solutions
Table 28. Takeda Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Takeda Recent Developments and Future Plans
Table 30. AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Sustained-release Medicine Product and Solutions
Table 33. AstraZeneca Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. AstraZeneca Recent Developments and Future Plans
Table 35. AbbVie Company Information, Head Office, and Major Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Sustained-release Medicine Product and Solutions
Table 38. AbbVie Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. AbbVie Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Sustained-release Medicine Product and Solutions
Table 43. Pfizer Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Collegium Pharmaceutical, Inc Company Information, Head Office, and Major Competitors
Table 46. Collegium Pharmaceutical, Inc Major Business
Table 47. Collegium Pharmaceutical, Inc Sustained-release Medicine Product and Solutions
Table 48. Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Collegium Pharmaceutical, Inc Recent Developments and Future Plans
Table 50. Endo Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. Endo Pharmaceuticals Major Business
Table 52. Endo Pharmaceuticals Sustained-release Medicine Product and Solutions
Table 53. Endo Pharmaceuticals Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Endo Pharmaceuticals Recent Developments and Future Plans
Table 55. Shanghai Shyndec Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. Shanghai Shyndec Pharmaceutical Major Business
Table 57. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product and Solutions
Table 58. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Shanghai Shyndec Pharmaceutical Recent Developments and Future Plans
Table 60. Zhuhai Rundu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 61. Zhuhai Rundu Pharmaceutical Major Business
Table 62. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product and Solutions
Table 63. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Zhuhai Rundu Pharmaceutical Recent Developments and Future Plans
Table 65. China Res Double-Crane Company Information, Head Office, and Major Competitors
Table 66. China Res Double-Crane Major Business
Table 67. China Res Double-Crane Sustained-release Medicine Product and Solutions
Table 68. China Res Double-Crane Sustained-release Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. China Res Double-Crane Recent Developments and Future Plans
Table 70. Global Sustained-release Medicine Revenue (USD Million) by Players (2019-2024)
Table 71. Global Sustained-release Medicine Revenue Share by Players (2019-2024)
Table 72. Breakdown of Sustained-release Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Sustained-release Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Sustained-release Medicine Players
Table 75. Sustained-release Medicine Market: Company Product Type Footprint
Table 76. Sustained-release Medicine Market: Company Product Application Footprint
Table 77. Sustained-release Medicine New Market Entrants and Barriers to Market Entry
Table 78. Sustained-release Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Sustained-release Medicine Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Sustained-release Medicine Consumption Value Share by Type (2019-2024)
Table 81. Global Sustained-release Medicine Consumption Value Forecast by Type (2025-2030)
Table 82. Global Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024)
Table 83. Global Sustained-release Medicine Consumption Value Forecast by Distribution Channel (2025-2030)
Table 84. North America Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 87. North America Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 88. North America Sustained-release Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Sustained-release Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 93. Europe Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 94. Europe Sustained-release Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Sustained-release Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 99. Asia-Pacific Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 100. Asia-Pacific Sustained-release Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Sustained-release Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 105. South America Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 106. South America Sustained-release Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Sustained-release Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Sustained-release Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Sustained-release Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Sustained-release Medicine Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 111. Middle East & Africa Sustained-release Medicine Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 112. Middle East & Africa Sustained-release Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Sustained-release Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Sustained-release Medicine Raw Material
Table 115. Key Suppliers of Sustained-release Medicine Raw Materials
LIST OF FIGURES
Figure 1. Sustained-release Medicine Picture
Figure 2. Global Sustained-release Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Sustained-release Medicine Consumption Value Market Share by Type in 2023
Figure 4. Original Ground Medicine
Figure 5. Generic Medicine
Figure 6. Global Sustained-release Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Sustained-release Medicine Consumption Value Market Share by Distribution Channel in 2023
Figure 8. Hospital Picture
Figure 9. Drugstore Picture
Figure 10. Other Picture
Figure 11. Global Sustained-release Medicine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Sustained-release Medicine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Sustained-release Medicine Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Sustained-release Medicine Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Sustained-release Medicine Consumption Value Market Share by Region in 2023
Figure 16. North America Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Sustained-release Medicine Revenue Share by Players in 2023
Figure 22. Sustained-release Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Sustained-release Medicine Market Share in 2023
Figure 24. Global Top 6 Players Sustained-release Medicine Market Share in 2023
Figure 25. Global Sustained-release Medicine Consumption Value Share by Type (2019-2024)
Figure 26. Global Sustained-release Medicine Market Share Forecast by Type (2025-2030)
Figure 27. Global Sustained-release Medicine Consumption Value Share by Distribution Channel (2019-2024)
Figure 28. Global Sustained-release Medicine Market Share Forecast by Distribution Channel (2025-2030)
Figure 29. North America Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 31. North America Sustained-release Medicine Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 37. Europe Sustained-release Medicine Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 39. France Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 45. Asia-Pacific Sustained-release Medicine Consumption Value Market Share by Region (2019-2030)
Figure 46. China Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 49. India Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 54. South America Sustained-release Medicine Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 59. Middle East and Africa Sustained-release Medicine Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 63. Sustained-release Medicine Market Drivers
Figure 64. Sustained-release Medicine Market Restraints
Figure 65. Sustained-release Medicine Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Sustained-release Medicine in 2023
Figure 68. Manufacturing Process Analysis of Sustained-release Medicine
Figure 69. Sustained-release Medicine Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Sustained-release Medicine Picture
Figure 2. Global Sustained-release Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Sustained-release Medicine Consumption Value Market Share by Type in 2023
Figure 4. Original Ground Medicine
Figure 5. Generic Medicine
Figure 6. Global Sustained-release Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Sustained-release Medicine Consumption Value Market Share by Distribution Channel in 2023
Figure 8. Hospital Picture
Figure 9. Drugstore Picture
Figure 10. Other Picture
Figure 11. Global Sustained-release Medicine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Sustained-release Medicine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Sustained-release Medicine Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Sustained-release Medicine Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Sustained-release Medicine Consumption Value Market Share by Region in 2023
Figure 16. North America Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Sustained-release Medicine Revenue Share by Players in 2023
Figure 22. Sustained-release Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Sustained-release Medicine Market Share in 2023
Figure 24. Global Top 6 Players Sustained-release Medicine Market Share in 2023
Figure 25. Global Sustained-release Medicine Consumption Value Share by Type (2019-2024)
Figure 26. Global Sustained-release Medicine Market Share Forecast by Type (2025-2030)
Figure 27. Global Sustained-release Medicine Consumption Value Share by Distribution Channel (2019-2024)
Figure 28. Global Sustained-release Medicine Market Share Forecast by Distribution Channel (2025-2030)
Figure 29. North America Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 31. North America Sustained-release Medicine Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 37. Europe Sustained-release Medicine Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 39. France Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 45. Asia-Pacific Sustained-release Medicine Consumption Value Market Share by Region (2019-2030)
Figure 46. China Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 49. India Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 54. South America Sustained-release Medicine Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Sustained-release Medicine Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Sustained-release Medicine Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 59. Middle East and Africa Sustained-release Medicine Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Sustained-release Medicine Consumption Value (2019-2030) & (USD Million)
Figure 63. Sustained-release Medicine Market Drivers
Figure 64. Sustained-release Medicine Market Restraints
Figure 65. Sustained-release Medicine Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Sustained-release Medicine in 2023
Figure 68. Manufacturing Process Analysis of Sustained-release Medicine
Figure 69. Sustained-release Medicine Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
